📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. (2022)

First Author: Daver NG

Attributed to: University of Oxford – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-22-0332

PubMed Identifier: 36218325

Publication URI: http://europepmc.org/abstract/MED/36218325

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancer discovery

Issue: 11

ISSN: 2159-8274